Overview
Andrew Gifford practices in Randwick, Australia. Mr. Gifford is rated as an Experienced expert by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, and Adult T-Cell Leukemia.
His clinical research consists of co-authoring 50 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Acute Lymphoblastic Leukemia (ALL).
Locations
North Shore, NSW, Australia
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Embryonal Tumor with Multilayered Rosettes
- Gliomatosis CerebriMr. Gifford isAdvanced. Learn about Gliomatosis Cerebri.
- NeuroblastomaMr. Gifford isAdvanced. Learn about Neuroblastoma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Mr. Gifford isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adult Soft Tissue SarcomaMr. Gifford isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Adult T-Cell LeukemiaMr. Gifford isExperienced. Learn about Adult T-Cell Leukemia.
- Brain Stem CancerMr. Gifford isExperienced. Learn about Brain Stem Cancer.
- Brain TumorMr. Gifford isExperienced. Learn about Brain Tumor.
- Diffuse Midline Glioma H3 K27M-MutantMr. Gifford isExperienced. Learn about Diffuse Midline Glioma H3 K27M-Mutant.